MoneyWorks4Me

Aurobindo Pharma board to consider Un-Audited Financial Results

29 Jul 2013 Evaluate

Aurobindo Pharma has informed that a Meeting of the Board of Directors of the Company will be held on August 09, 2013, to consider the Un-Audited Financial Results of the Company for the quarter ended June 30, 2013 (Q1).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..